Condition

ACC (3)

Adrenocortical Carcinoma (3)

Adrenal Cancer (1)

Cancer (1)

Metastatic Adrenocortical Carcinoma (1)

NET (1)

Neuroendocrine Tumors (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Arbutus Biopharma Corporation (1)

Memorial Sloan Kettering Cancer Center (1)

Millendo Therapeutics, Inc. (1)

Collaborator

Intervention

ablative radiotherapy (1)

atr-101 (1)

pembrolizumab (1)

tkm-080301 (1)

Study Documents

Intervention Type

drug (3)

radiation (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

acc

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Adrenocortical Carcinoma, ACC, Metastatic Adrenocortical Carcinoma Trial in United States (Ablative Radiotherapy, Pembrolizumab)

Recruiting

Adrenocortical Carcinoma
+2 more

Ablative Radiotherapy
Pembrolizumab

Basking Ridge, New Jersey
+6 more

Sep 27, 2023

Cancer, Neuroendocrine Tumors, NET Trial in United States (TKM-080301)

Completed

Cancer
+4 more

TKM-080301

Scottsdale, Arizona
+7 more

Jan 14, 2019

Adrenocortical Carcinoma, Adrenal Cancer, ACC Trial in Germany, United States (ATR-101)

Completed

Adrenocortical Carcinoma
+2 more

ATR-101

Tampa, Florida
+4 more

Nov 2, 2017